Clinical Trials Sponsored by Abell Foundation

Total 15814 results

Johns Hopkins University
Abell Foundation

Completed

Preventing Postpartum Depression in African American Home Visiting Clients

Depression

United States
Johns Hopkins University
Zanvyl and Isabelle Krieger Fund; Abell Foundation

Completed

Preconception Women's Health in Pediatric Practice Intervention

Women's Health | Preconception Care

United States
Abbell AB

Completed

Clinical Trial of Topical ABL01 Treatment of Onychomycosis

Onychomycosis of Toenail

Sweden
Johns Hopkins University
University of Chicago; Robert Wood Johnson Foundation; Abell Foundation; Elev8...

Completed

D-Stress Baltimore: School-based Mindfulness Instruction

Stress Disorders, Post-Traumatic | Mental Health Wellness 1 | Coping

United States
Johns Hopkins University
The Rita and Alex Hillman Foundation; Abell Foundation; Richman Foundation; Sherman... and other collaborators

Recruiting

Parenting for Tomorrow: A New Model for Supporting Preschool Children's Mental Health in Head Start

Parenting | Parenting Intervention

United States
Johns Hopkins University
National Institute on Aging (NIA); Retirement Research Foundation; Abell Foundation and other collaborators

Completed

The Baltimore Experience Corps Study

Aging | Generativity

United States
Bell International Laboratories

Completed

SOOTHER Trial to Treat Rectal Itch

Pruritus Ani

United States
ALK-Abelló A/S

Enrolling by invitation

Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis

Allergic Asthma | Allergic Rhinitis Due to House Dust Mite

China
Dascena
Cabell Huntington Hospital

Completed

Predictive algoRithm for EValuation and Intervention in SEpsis (PREVISE)

Sepsis | Septic Shock | Severe Sepsis

United States
ALK-Abelló A/S

Completed

Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX® (GT-20)

Allergic Rhinoconjunctivitis

Spain
ALK-Abelló A/S

Completed

Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)

Allergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
ALK-Abelló A/S

Completed

A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021) (AIRS)

Allergic Rhinoconjunctivitis
ALK-Abelló A/S

Completed

A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)

Allergy
ALK-Abelló A/S

Completed

Grazax Asthma Prevention (GAP)

Allergic Rhinitis

Finland
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of Pangramin SLIT HDM-mix in Subjects With House Dust Mite Induced Rhinitis

Allergic Rhinitis

China
ALK-Abelló A/S

Completed

Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber (AV-G-03)

Grass Pollen Induced Allergic Rhinoconjunctivitis

Germany
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ Mite Mix Immunotherapy (AV-M-01)

Allergic Rhinitis Due to Dust Mite

Spain
ALK-Abelló A/S

Completed

Avanz Phleum Pratense Maintenance Dose

Allergic Rhinoconjunctivitis

Germany
ALK-Abelló A/S

Completed

A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine (GT-19)

Allergic Rhinoconjunctivitis

Germany
ALK-Abelló A/S

Completed

Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis (GT-17)

Allergic Rhinitis | Grass Allergy

Italy
ALK-Abelló A/S

Completed

A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment

Grass Pollen Allergy

Denmark
ALK-Abelló A/S

Terminated

Comparison of Different Up-dosing Schedules With Osiris

Allergic Rhinitis

Poland
ALK-Abelló A/S

Completed

Safety of ALK Ragweed Tablet

Allergy

United States
ALK-Abelló A/S

Completed

Mite Asthma Pediatric Immunotherapy Trial (MAPIT)

Allergic Rhinitis Due to House Dust Mite | Allergic Asthma Due to Dermatophagoides Farinae | Allergic Asthma Due to Dermatophagoides Pteronyssinus

Poland, United Kingdom, Spain, United States, Russian Federation, Hungary, France, Bulgaria, Germany
ALK-Abelló A/S

Terminated

A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber (QUEST)

Allergic Rhinoconjunctivitis

Austria, China
ALK-Abelló A/S

Completed

Impact of AIT on Allergic Rhinitis and Asthma

Allergy | Respiratory Disease

Denmark
ALK-Abelló A/S

Completed

A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)

Conjunctivitis | Rhinitis Allergic
ALK-Abelló A/S

Completed

Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006)

Rhinitis, Allergic, Seasonal
ALK-Abelló A/S

Completed

Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED)

Conjunctivitis | Rhinitis; Allergic, With Asthma
ALK-Abelló A/S

Completed

Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234)

Rhinitis, Allergic | Conjunctivitis
ALK-Abelló A/S

Completed

Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)

Allergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
ALK-Abelló A/S

Completed

Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)

Perennial Allergic Rhinitis | Seasonal Allergic Rhinitis
ALK-Abelló A/S

Completed

A Trial of Grazax in Subjects With Hayfever

Allergy

United States
ALK-Abelló A/S

Completed

A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy (SUMMIT)

Allergic Rhinitis

France
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ Olive Immunotherapy

Allergic Rhinitis Due to Olea Europaea Pollen

Spain
ALK-Abelló A/S

Completed

A Trial of the ALK Grass Tablet in Subjects With Hayfever

Allergy

Denmark
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects

Asthma

Denmark
ALK-Abelló A/S

Completed

Assessment of Grazax® Treatment Compliance

Allergy

Austria
ALK-Abelló A/S

Completed

Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets

Allergy

Spain
ALK-Abelló A/S

Recruiting

Observational Study of Allergic Rhinitis in Children (ORACLE)

Allergic Rhinitis

France
ALK-Abelló A/S

Active, not recruiting

House Dust Mite Allergy Trial In Children (MATIC)

Allergic Rhinitis Due to Dermatophagoides Farinae | Allergic Rhinitis Due to Dermatophagoides Pteronyssinus | Allergic Rhinitis Due to House Dust Mite

Spain, Russian Federation, United States, Poland, Bulgaria, Canada, France, Germany, Lithuania, Slovakia, Ukraine
ALK-Abelló A/S

Completed

Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate

Allergic Rhinitis Due to Grass Pollens

Spain
ALK-Abelló A/S

Completed

Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)

Allergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
ALK-Abelló A/S

Completed

A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet (MT-06)

House Dust Mite Allergy

France
ALK-Abelló A/S

Completed

Intraseasonal Short-time Up-dosing With Alutard SQ Grasses

Allergy

Germany
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis

Atopic Dermatitis

Germany
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy

Allergic Rhinoconjunctivitis

Spain
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy (AV-X-02)

Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen

Spain
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy

Allergic Rhinoconjunctivitis

Spain
ALK-Abelló A/S

Completed

A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy Tablet

Birch Pollen Allergy

Finland, Netherlands

Clinical Trials Sponsored by Abell Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations